Fas antigen/APO-1 (CD95) expression on myeloma cells

被引:15
作者
Shima, Y
Nishimoto, N
Yoshizaki, K
Kishimoto, T
机构
[1] Department of Medicine III, Osaka University Medical School, Osaka
[2] Department of Medicine III, Osaka University Medical School, Suita City, Osaka 565, 2-2, Yamada-oka
关键词
myeloma; apoptosis; Fas antigen APO-1 (CD95); Bcl-2;
D O I
10.3109/10428199609054860
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Many factors involved in the proliferation of myelomas have been reported, and the relationship between these factors and the pathogenesis of multiple myeloma has been discussed. We found that most myeloma cells express Fas antigen/APO-1 (CD95), a cell surface antigen that mediates apoptosis. However only some cells are sensitive to anti-Fas antibody and undergo apoptosis. These data indicate that some multiple myelomas are generated not only by cell proliferation but also by cell immortalization The mechanism by which myelomas are immortalized is still unclear, but Bcl-2, Bcl-x(L), adult T cell leukemia derived factor (ADF), soluble Pas are all candidate factors for this mechanism. The possibility als, exists that inducers of apoptosis, e.g. tumor necrosis factor(TNF), interleukin-1 beta-converting enzyme(ICE), Bcl-x(S), or Bar, do not have a lethal effect. In this review, we focus on the system that immortalizes myeloma cells, and suggest the possibility that multiple myeloma constitutes one group of cells which cannot undergo apoptosis in the bone marrow.
引用
收藏
页码:521 / +
页数:1
相关论文
共 93 条
[1]  
ANDERSON KC, 1989, BLOOD, V73, P1915
[2]   INTERLEUKIN-3 AND INTERLEUKIN-6 SYNERGISTICALLY PROMOTE THE PROLIFERATION AND DIFFERENTIATION OF MALIGNANT PLASMA-CELL PRECURSORS IN MULTIPLE-MYELOMA [J].
BERGUI, L ;
SCHENA, M ;
GAIDANO, G ;
RIVA, M ;
CALIGARISCAPPIO, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (02) :613-618
[3]  
BIAVA C, 1965, AM J PATHOL, V46, P775
[4]   BCL-X, A BCL-2-RELATED GENE THAT FUNCTIONS AS A DOMINANT REGULATOR OF APOPTOTIC CELL-DEATH [J].
BOISE, LH ;
GONZALEZGARCIA, M ;
POSTEMA, CE ;
DING, LY ;
LINDSTEN, T ;
TURKA, LA ;
MAO, XH ;
NUNEZ, G ;
THOMPSON, CB .
CELL, 1993, 74 (04) :597-608
[5]   MOLECULAR-CLONING OF THE INTERLEUKIN-1-BETA CONVERTING ENZYME [J].
CERRETTI, DP ;
KOZLOSKY, CJ ;
MOSLEY, B ;
NELSON, N ;
VANNESS, K ;
GREENSTREET, TA ;
MARCH, CJ ;
KRONHEIM, SR ;
DRUCK, T ;
CANNIZZARO, LA ;
HUEBNER, K ;
BLACK, RA .
SCIENCE, 1992, 256 (5053) :97-100
[6]   PROTECTION FROM FAS-MEDIATED APOPTOSIS BY A SOLUBLE FORM OF THE FAS MOLECULE [J].
CHENG, JH ;
ZHOU, T ;
LIU, CD ;
SHAPIRO, JP ;
BRAUER, MJ ;
KIEFER, MC ;
BARR, PJ ;
MOUNTZ, JD .
SCIENCE, 1994, 263 (5154) :1759-1762
[7]  
COHEN JJ, 1991, ADV IMMUNOL, V50, P55
[8]  
COZZOLINO F, 1989, BLOOD, V74, P380
[9]   GENETIC-CONTROL OF PROGRAMMED CELL-DEATH IN THE NEMATODE C-ELEGANS [J].
ELLIS, HM ;
HORVITZ, HR .
CELL, 1986, 44 (06) :817-829
[10]  
ELLIS RE, 1991, DEVELOPMENT, V112, P591